Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 7 | BMC Cancer

Fig. 7

From: Comprehensive network pharmacology and experimentation to unveil the therapeutic efficacy and mechanisms of gypenoside LI in anaplastic thyroid cancer

Fig. 7

Gyp LI inhibited the proliferation of ATC cells. (A) Survival rate of 8305 C cells treated with different concentrations of Gyp LI. (B) Survival rate of C643 cells treated with different concentrations of Gyp LI. (C) The ATC cells treated with Gyp LI formed fewer colonies, as indicated using crystal violet staining. (D) Statistical analysis of the colony formation assays. The y-axis indicates the total number of clones in one well

Back to article page